184 related articles for article (PubMed ID: 4554158)
1. Hypertension with aldosterone excess.
Brown JJ; Fraser R; Lever AF; Robertson JI
Br Med J; 1972 May; 2(5810):391-6. PubMed ID: 4554158
[No Abstract] [Full Text] [Related]
2. Hypertension with primary and secondary hyperaldosteronism.
Biglieri EG
Postgrad Med; 1972 Sep; 52(3):78-82. PubMed ID: 5055885
[No Abstract] [Full Text] [Related]
3. The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess.
Beevers DG; Brown JJ; Ferriss JB; Fraser R; Lever AF; Robertson JI
Am Heart J; 1973 Sep; 86(3):404-14. PubMed ID: 4592546
[No Abstract] [Full Text] [Related]
4. Secondary aldosteronism: with observations on the definition of hypokalemia.
Kaplan NM
Am J Clin Pathol; 1970 Sep; 54(3):316-23. PubMed ID: 4319208
[No Abstract] [Full Text] [Related]
5. Significance of renin and angiotensin in hypertension.
Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Padfield PL; Semple PF; Robertson JI
Cardiovasc Clin; 1978; 9(1):55-89. PubMed ID: 352522
[No Abstract] [Full Text] [Related]
6. [Renin-angiotensin-(aldosterone)-system-clinical aspects].
Börner H
Z Gesamte Inn Med; 1973 Dec; 28(24):757-62. PubMed ID: 4360460
[No Abstract] [Full Text] [Related]
7. The clinical value of renin and angiotensin estimations.
Beevers DG; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Semple PF; Tree M
Kidney Int Suppl; 1975 Sep; ():S181-201. PubMed ID: 1104971
[No Abstract] [Full Text] [Related]
8. The renin-angiotensin-aldosterone system in primary and secondary hypertension.
del Greco F; Huang CM; Quintanilla A; Krumlovsky F; Roxe DM; Santhanam S
Ann Clin Lab Sci; 1981; 11(6):497-505. PubMed ID: 6119955
[TBL] [Abstract][Full Text] [Related]
9. [What is the importance of renin determination for the clinician?].
Meyer P
Mars Med; 1971; 108(11):751-3. PubMed ID: 5158027
[No Abstract] [Full Text] [Related]
10. Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition?
Davies DL; Beevers DG; Brown JJ; Cumming AM; Fraser R; Lever AF; Mason PA; Morton JJ; Robertson JI; Titterington M; Tree M
J Endocrinol; 1979 May; 81(2):79P-91P. PubMed ID: 458346
[No Abstract] [Full Text] [Related]
11. [Major hyperaldosteronisms secondary to unilateral nephropathy and surgically curable].
Mornex R; Perrin J; Bryon PA; Servonnat P; Gliere R; Bomel J; Fauriel N
Sem Hop; 1972 Jan; 48(4):253-66. PubMed ID: 4338346
[No Abstract] [Full Text] [Related]
12. [Importance of renin-angiotensin-aldosterone system in diverse forms of hypertension].
Werning C; Weidmann P; Vetter W; Stiel D; Schweikert HU; Siegenthaler W
Schweiz Rundsch Med Prax; 1970 May; 59(20):730-7. PubMed ID: 4321141
[No Abstract] [Full Text] [Related]
13. Plasma renin concentration in human hypertension . II. Renin in relation to aetiology.
Brown JJ; Davies DL; Lever AF; Robertson JI
Br Med J; 1965 Nov; 2(5472):1215-9. PubMed ID: 5849134
[No Abstract] [Full Text] [Related]
14. Renin-aldosterone response to dexamethasone in glucocorticoid-suppressible hyperaldosteronism is altered by coexistent renal artery stenosis.
Stowasser M; Gordon RD; Klemm SA; Tunny TJ
J Clin Endocrinol Metab; 1993 Sep; 77(3):800-4. PubMed ID: 8396580
[TBL] [Abstract][Full Text] [Related]
15. [Hypertension. Review of the literature of recent years].
Albrecht KF
Urologe; 1969; 8(1):25-8. PubMed ID: 4902332
[No Abstract] [Full Text] [Related]
16. Oral contraceptive hypertension.
Laragh JH
Postgrad Med; 1972 Sep; 52(3):98-105. PubMed ID: 4341362
[No Abstract] [Full Text] [Related]
17. [Arterial hypertension with hypokalemia].
Montanari G; Zanaletti F; Quadrelli GC; Di Battista F; Ongis GA; Fraschini A; Zinzalini G; Abbiati C
Minerva Med; 1988 Mar; 79(3):209-14. PubMed ID: 2966307
[TBL] [Abstract][Full Text] [Related]
18. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
[TBL] [Abstract][Full Text] [Related]
19. Pseudohyperaldosteronism from liquorice-containing laxatives.
Scali M; Pratesi C; Zennaro MC; Zampollo V; Armanini D
J Endocrinol Invest; 1990 Nov; 13(10):847-8. PubMed ID: 2096161
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of mineralocorticoid hypertension.
Biglieri EG
Hypertension; 1991 Feb; 17(2):251-61. PubMed ID: 1846843
[No Abstract] [Full Text] [Related]
[Next] [New Search]
